CMS to make 100% of claims data public
This article was originally published in The Gray Sheet
Executive Summary
Researchers will soon get a gift from Medicare - they'll be able to order selections of data from up to 100% of claims. Steve Phurrough, CMS Coverage & Analysis Group director, told an audience at the Transcatheter Cardiovascular Therapeutics meeting Oct. 25 in Washington, D.C., that the database will include all Medicare claims data, beginning with 2005, including inpatient, outpatient, nursing home and durable medical equipment data. "You will be able as a researcher to say to us, 'I want to see all your data on MI, or kidney stones,' whatever it is that you want, and it will be 100% of our claims," he said. At present, researchers can only request a selection of about 5% of the data. Phurrough hopes that with expanded availability, mandated by the Medicare Modernization Act, CMS will see more clinical data that can be applied directly to the Medicare population...
You may also be interested in...
EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
COVID-19: US Acted To Beat Other Countries To Next 1.25M Doses Of Regeneron Cocktail
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: